Brian L. Koopman

Brian L. Koopman

Principal Financial OfficeratUtah Medical Products· In proxies 2021–2025

Pay in FY2025+7% from the year before · Utah Medical Products stock -9.0% the same year

Brian L. Koopman was paid $179.1K in FY2025 (Dec), up 7%. Utah Medical Products stock fell 9.0% that year.

Pay$100 in the stock at the end of FY20 → $69
Pay is from the Summary Compensation Table of each Utah Medical Products proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Utah Medical ProductsPublic company · 5 yr
    • Principal Financial Officer2021 – Present · 5 yrStock in role -16%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?